Apyx Medical APYX Cash Flow Statement (2011-2026)

NASDAQ APYX
$3.14 -0.01 (-0.32%)
At close: Aug 20, 2026 · 11:05 AM UTC
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-4.23M-2.01M-5.97M-5.45M-5.79M-6.07M-3.53M-1.02M-4.67M-9.62M-7.59M-6.59M-4.72M-6.88M-4.17M-3.74M-1.96M-4.26M-2.14M-3.07M
Share-based Compensation (Quarter)
1.18M1.34M1.65M1.71M1.69M-5.06M1.37M1.48M1.35M0.91M1.13M1.05M1.00M-2.99M0.45M0.52M0.53M-1.50M0.31M1.07M
Deferred Taxes (Quarter)
Asset Writedowns and Impairment (Quarter)
0.01M0.07M0.14M0.14M-0.00M0.03M-0.14M0.20M0.12M0.10M0.01M0.05M0.00M0.34M0.03M0.14M0.03M0.14M0.01M0.09M
Cash from Operations (Quarter)
-3.60M0.21M-4.52M-5.87M-5.36M-4.53M-1.88M-4.85M3.70M-2.21M-6.34M-4.33M-4.44M-2.94M-0.70M-1.23M-3.54M-2.53M-0.57M-3.49M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)
0.22M0.22M0.23M0.49M0.23M0.24M0.24M0.24M0.24M0.24M
Depreciation & Amortization (CF) (Quarter)
0.23M0.23M0.23M0.25M0.22M0.20M0.20M0.15M0.19M0.15M0.16M0.16M0.14M0.14M0.14M0.13M0.16M0.22M0.20M0.20M
Change in Working Capital
Change in Receivables (Quarter)
2.51M1.73M-0.47M-1.76M-1.04M1.35M-0.84M2.28M0.75M1.38M-1.48M0.29M0.31M2.91M-3.94M-0.47M1.84M3.90M-3.95M0.95M
Change in Inventory (Quarter)
0.78M0.88M0.37M2.82M2.48M-0.10M-0.88M0.34M0.13M-1.06M-0.14M-0.41M-0.35M-1.36M0.20M0.52M0.86M-0.51M0.84M1.31M
Change in Account Payables (Quarter)
0.26M-0.40M-0.05M0.08M-0.47M0.51M-0.78M0.75M-0.59M0.64M-0.60M0.25M-0.47M0.76M-0.33M0.51M0.33M-0.15M-0.41M-0.44M
Change in Accured Expenses (Quarter)
1.05M1.79M-1.81M1.81M0.07M-2.03M0.81M1.43M-1.57M-0.10M-0.69M0.09M-0.86M0.43M0.08M0.55M-1.76M0.32M
Other Working Capital Changes (Quarter)
-1.14M-1.38M-0.65M1.20M-0.03M0.00M-0.86M0.92M0.64M-0.51M-0.24M-0.42M0.12M-0.32M-0.04M-0.40M0.42M-0.23M0.15M-0.29M
Investing Activities
Capital Expenditures (Quarter)
0.17M0.33M0.28M0.40M0.19M0.14M0.11M0.16M0.17M0.09M0.04M0.29M0.15M0.24M0.06M0.27M0.52M0.28M0.06M0.07M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)
-0.17M-0.33M-0.28M-0.40M-0.19M-0.14M-0.11M7.11M-0.17M-0.09M-0.04M-0.29M-0.15M-0.24M-0.06M-0.27M-0.52M-0.28M-0.06M-0.07M
Financing Activities
Other financing activities (Quarter)
0.59M-0.44M0.06M0.43M0.09M
Cash from Financing Activities (Quarter)
-0.03M-0.04M0.10M0.00M0.13M-0.01M8.11M0.05M0.16M23.84M-0.01M-0.01M-0.01M6.76M0.03M0.03M0.04M9.48M0.08M-0.01M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)
0.04M0.13M0.06M0.10M0.19M0.04M-0.06M-0.08M-0.03M-0.02M0.01M0.02M-0.07M0.15M0.00M-0.24M-0.16M-0.07M-0.05M0.04M
Change in Cash (Quarter)
-3.77M-0.03M-4.64M-6.17M-5.23M-4.64M6.06M2.22M3.65M21.52M-6.37M-4.60M-4.67M3.73M-0.73M-1.71M-4.17M6.61M-0.60M-3.52M
Free Cash Flow (Quarter)
-3.77M-0.12M-4.80M-6.27M-5.55M-4.67M-1.99M-5.01M3.52M-2.31M-6.38M-4.62M-4.59M-3.18M-0.76M-1.50M-4.05M-2.80M-0.63M-3.56M
Net Cash Flow (Quarter)
-3.81M-0.16M-4.70M-6.27M-5.42M-4.68M6.12M2.31M3.69M21.54M-6.38M-4.62M-4.60M3.58M-0.73M-1.47M-4.01M6.68M-0.55M-3.56M